Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | APP | P05067 | 1/20 | 0.44 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.44 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.44 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.41 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.41 |
| ▸ | S1PR1 | P21453 | 6/20 | 0.40 |
| ▸ | S1PR5 | Q9H228 | 5/20 | 0.38 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.37 |
| ▸ | S1PR3 | Q99500 | 3/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.36 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.36 |
| ▸ | DHODH | Q02127 | 1/20 | 0.36 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18411541 | 0.86 | CYP3A4 (0.50) | CYP3A4CYP2C9APPPDE3BPDE3A | |
| SCHEMBL19803789 | 0.82 | CYP3A4 (0.52) | CYP3A4CYP2C9APPPDE3BPDE3A | |
| SCHEMBL20989700 | 0.81 | CYP2C9 (0.41) | CYP3A4CYP2C9AKR1C3AKR1C2PDE3B | |
| SCHEMBL19624876 | 0.81 | HTR2A (0.46) | CYP3A4CYP2C9APPPDK2KMT2A | |
| SCHEMBL14525326 | 0.79 | HSP90AA1 (0.46) | CYP3A4CYP2C9APPS1PR1HSP90AA1 | |
| SCHEMBL23854348 | 0.79 | ESR2 (0.45) | CYP3A4CYP2C9APPS1PR1S1PR5 | |
| SCHEMBL19883163 | 0.79 | S1PR1 (0.44) | CYP3A4CYP2C9APPS1PR1S1PR5 | |
| SCHEMBL127034 | 0.79 | ACMSD (0.44) | CYP3A4CYP2C9PDK2HSP90AA1GAA | |
| SCHEMBL23483046 | 0.78 | ESR2 (0.45) | CYP3A4CYP2C9APPS1PR1S1PR5 | |
| SCHEMBL14173389 | 0.77 | SLC6A3 (0.42) | CYP3A4CYP2C9APPAKR1C3AKR1C2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200299578-A1 | POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2020-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200299578-A1 | POLYMERIZABLE COMPOUND HAVING METHOXYMETHYL ACRYLIC GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | SP1, CCND1, CPNE4 | CYP3A4 1084/4885CYP2C9 3951/4885APP 723/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.